The Start2Cure MS Initiative is founded by Aat van Herk. It is our mission to take the lead in supporting scientists tackling the toughest challenges in MS research on a global scale. We invest in young talent, bold new ideas and scientific approaches to initiate and stimulate transformative medical research to finally end Multiple Sclerosis within 50 years.
To initiate a paradigm shift in Multiple Sclerosis research, Start2Cure aims to enable and drive breakthrough treatments to advance restorative therapies and medical interventions reaching patients via targeted funding programs.
The Start2Cure MS Initiative is a nonprofit foundation. Through our Global Research Grants and Awards Program we enable scientists to accelerate scientific breakthroughs to deliver new therapeutics, medical devices or diagnostics for patients with Multiple Sclerosis. This program will deliver various research grants and awards to enable and initiate (translational) research in key research area’s that address unmet needs to potentially and finally solve Multiple Sclerosis and ultimately restore neurological function.
Start2Cure’s innovative investment program will fund high-risk,
high-reward translational and potentially transformative medical research.
Go to find out more information about our projects and their goals here.
Let’s end Multiple Sclerosis together. Follow the steps to join our mission.
Sign up for periodic news updates, and event invitations.